header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

Research

CENTRAL PAIN SENSITISATION AND RADIOGRAPHIC OSTEOARTHRITIS AFTER TOTAL JOINT REPLACEMENT

European Orthopaedic Research Society (EORS) 2015, Annual Conference, 2–4 September 2015. Part 2.



Abstract

Background

To investigate whether the interaction between pre-operative widespread hyperalgesia and radiographic osteoarthritis (OA) was associated with pain severity before and after total hip replacement (THR) and total knee replacement (TKR).

Methods

Data were analysed from 232 patients receiving THR and 241 receiving TKR. Pain was assessed pre-operatively and at 12 months post-operatively using the WOMAC Pain Scale. Widespread hyperalgesia was assessed through forearm pressure pain thresholds (PPTs) measured using an algometer. The severity of radiographic OA was evaluated using the Kellgren and Lawrence scheme. Statistical analysis was conducted using linear regression and multilevel models, and adjusted for confounding variables.

Results

Pre-operative

In knee patients, there was weak evidence that the effect of PPTs on pain severity was greater in patients with more severe OA compared to patients with less severe OA (Grade 3 OA: ß=0.96 vs Grade 4 OA: ß=4.03). However, in hip patients, the effect of PPTs on pain severity did not differ with the extent of radiographic OA (Grade 3 OA: ß=3.95 vs Grade 4 OA: ß=3.67).

Post-operative

Patients undergoing TKR with less severe OA who had lower PPTs (greater widespread hyperalgesia) benefitted less from surgery than patients with higher PPTs (Grade 3 OA: ß=2.28). Conversely, patients undergoing THR with more severe OA who had lower PPTs benefited more from surgery than patients with higher PPTs (Grade 4 OA: ß=−2.92).

Conclusion

Central sensitisation may be a determinant of how much patients benefit from joint replacement, but the effect varies by joint and severity of structural joint changes.

Level of Evidence

2

Approvals

The APEX trials were registered as an International Standardised Randomised Controlled Trial (96095682), approved by Southampton and South West Hampshire Research Ethics Committee (09/H0504/94) and all participants provided informed written consent.